- Patent Foramen Ovale (PFO) Closure Devices Market size is expected to rise by 2026 owing to increasing prevalence, escalating preferences for minimally-invasive, safety, technically feasible ...

TCT 579: The Incidence of Atrial Fibrillation After Percutaneous Patent Foramen Ovale (PFO) Closure Detected by Implantable Loop Recorders (ILR) Receive the the latest news, research, and ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced that the FDA has approved its patent foramen ovale occlusion system for patients with a PFO and ...

Data indicate that there could be a link between cryptogenic thromboembolic events and patent foramen ovale (PFO). Although controversial, increasing numbers of patients are undergoing transcatheter ...

The prevalence of patent foramen ovale among patients with cryptogenic stroke is higher than that in the general population. Closure with a percutaneous device is often recommended in such patients, ...

Percutaneous closure of patent foramen ovale (PFO) is a widely used procedure, but the long-term safety and efficacy of the technique have not been investigated. This prospective, observational, ...

DUBLIN--(BUSINESS WIRE)--The "US Market Report for Patent Foramen Ovale Devices 2018 - MedCore" report has been added to Research and Markets' offering. Some studies have suggested that PFO closure ...

† New-onset migraine was noted in ten patients. ASD: Atrial septal defect; NA: Not assessed; NR: Not reported; PFO: Patent foramen ovale. Box 1. The 'embolic' hypothesis. The following arguments ...

Evidence-based recommendations on percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers. This involves passing a device through a large ...

This section describes safety outcomes from the published literature that the Committee considered as part of the evidence about this procedure. For more detailed information on the evidence, see the ...